CD19 and rheumatoid arthritis: Indeed, we observed that, compared with CD19+CD24hiCD27+ B cells from OA SF and RA PB, markedly higher percentages of CD19+CD24hiCD27+RANKL+ B cells in the SF of patients with RA (Fig. 4a).